The difficulties also occur in cryptic gene fusions, for example, NUP98-NSD1, CBFA2T3–GLIS2, and MNX1–ETV6, which predict poor outcomes in pediatric and young adult AML (Grimwade et al., 2016). Here, MNX1 is linked to acute myeloid leukemia.